Related references
Note: Only part of the references are listed.Factors That Predict Response of Patients With Hepatitis B e Antigen-Positive Chronic Hepatitis B to Peginterferon-Alfa
Erik H. C. J. Buster et al.
GASTROENTEROLOGY (2009)
Peginterferon Alfa-2a Plus Ribavirin for the Treatment of Dual Chronic Infection With Hepatitis B and C Viruses
Chun-Jen Liu et al.
GASTROENTEROLOGY (2009)
Chronic Hepatitis B: Update 2009
Anna S. F. Lok et al.
HEPATOLOGY (2009)
Relapse of hepatitis B in HBeAg-negative chronic hepatitis B patients who discontinued successful entecavir treatment: The case for continuous antiviral therapy
Daniel Shouval et al.
JOURNAL OF HEPATOLOGY (2009)
Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update
Yun-Fan Liaw et al.
HEPATOLOGY INTERNATIONAL (2008)
Boceprevir (B) combination therapy in null responders (NR): Response dependent on interferon responsiveness
E. Schiff et al.
JOURNAL OF HEPATOLOGY (2008)
Tenofovir Disoproxil Fumarate versus Adefovir Dipivoxil for Chronic Hepatitis B
Patrick Marcellin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Drug therapy - Hepatitis B virus infection
Jules L. Dienstag
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Telbivudine versus lamivudine in patients with chronic hepatitis B
Ching-Lung Lai et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
A pilot study of extended duration peginterferon alfa-2a for patients with hepatitis B e antigen-negative chronic hepatitis B
Robert G. Gish et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)
Predicting response to peginterferon α-2a, lamivudine and the two combined for HBeAg-negative chronic hepatitis B
F. Bonino et al.
GUT (2007)
Characteristics of patients with chronic hepatitis B in France: Predominant frequency of HBe antigen negative cases
Jean-Pierre Zarski et al.
JOURNAL OF HEPATOLOGY (2006)
Interferon α-2b with and without ribavirin in the treatment of hepatitis B e antigen-positive chronic hepatitis B:: A randomized study
CJ Liu et al.
HEPATOLOGY (2006)
Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B
CL Lai et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Mechanism of action of interferon and ribavirin in treatment of hepatitis C
JJ Feld et al.
NATURE (2005)
Response to interferon alfa is hepatitis B virus genotype dependent:: genotype A is more sensitive to interferon than genotype D
A Erhardt et al.
GUT (2005)
Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B
SJ Hadziyannis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Peginterferon alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B
GKK Lau et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised
HLA Janssen et al.
LANCET (2005)
Peginterferon-α2a and ribavirin combination therapy in chronic hepatitis C -: A randomized study of treatment duration and ribavirin dose
SJ Hadziyannis et al.
ANNALS OF INTERNAL MEDICINE (2004)
Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis B
P Marcellin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Long-term suppression of hepatitis B e antigen-negative chronic hepatitis B by 24-month interferon therapy
P Lampertico et al.
HEPATOLOGY (2003)
Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B
SJ Hadziyannis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection.
MW Fried et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
World-wide epidemiology of HBeAg-negative chronic hepatitis B and associated precore and core promoter variants
ML Funk et al.
JOURNAL OF VIRAL HEPATITIS (2002)
Hepatitis B e antigen-negative chronic hepatitis B
SJ Hadziyannis et al.
HEPATOLOGY (2001)
Interferon α treatment and retreatment of hepatitis B e antigen-negative chronic hepatitis B
EK Manesis et al.
GASTROENTEROLOGY (2001)
Hepatitis B virus-specific T-cell proliferation and cytokine secretion in chronic hepatitis B e antibody-positive patients treated with ribavirin and interferon alfa
MA Rico et al.
HEPATOLOGY (2001)
Long-term follow-up of patients with anti-HBe/HBV DNA-positive chronic hepatitis B treated for 12 months with lamivudine
T Santantonio et al.
JOURNAL OF HEPATOLOGY (2000)
Pilot study of combination therapy with ribavirin and interferon alfa for the retreatment of chronic hepatitis B e antibody-positive patients
T Cotonat et al.
HEPATOLOGY (2000)